Earlier this year, TrialSite reported on a novel cancer drug known as EXO-CD24 under development at Tel Aviv Sourasky Medical Center (Ichilov Hospital) that demonstrated compelling…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.